Publications – Center for Communicable Disease Dynamics

Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing schedule, vaccine sentiment, targeting strategy, and duration of protection.

Author(s): Nikitin D, Whittles LK, Imai-Eaton JW, White PJJournal: J Infect DisPMID: 38630583 June 2024

Observational evidence suggests the 4CMenB meningococcal vaccine may partially protect against gonorrhea, with one dose being two-thirds as protective as…

Future HIV epidemic trajectories in South Africa and projected long-term consequences of reductions in general population HIV testing: a mathematical modelling study.

Author(s): Rautenbach SP, Whittles LK, Meyer-Rath G, Jamieson L, Chidarikire T, Johnson LF, Imai-Eaton JWJournal: Lancet Public HealthPMID: 38553141 April 2024

After successful intensive interventions to rapidly increase HIV awareness, coverage of antiretroviral therapy (ART), and viral suppression, HIV programmes in…

Spatiotemporal Trends in Group A Streptococcal Pharyngitis in the United States.

Author(s): Kline MC, Kissler SM, Whittles LK, Barnett ML, Grad YHJournal: Clin Infect DisPMID: 38373257 February 2024

Group A Streptococcus (GAS) causes an estimated 5.2 million outpatient visits for pharyngitis annually in the United States (U.S.) with…

Spatiotemporal Trends in Group A Streptococcal Pharyngitis in the United States.

Author(s): Kline MC, Kissler SM, Whittles LK, Barnett ML, Grad YHJournal: medRxivPMID: 38014331 November 2023

Group A (GAS) causes an estimated 5.2 million outpatient visits for pharyngitis annually in the United States (U.S.) with incidence…

Age Patterns of HSV-2 Incidence and Prevalence in Two Ugandan Communities: A Catalytic Incidence Model Applied to Population-Based Seroprevalence Data.

Author(s): Whittles LK, Galiwango RM, Mpagazi J, Tobian AAR, Ssekubugu R, Jackson J, Peer AD, Kennedy C, Nakalanzi M, Ndyanabo A, Kigozi G, Chang LW, Serwadda D, Manabe YC, Gaydos CA, Laeyendecker O, Quinn TC, Reynolds SJ, Kagaayi J, Eaton JW, Grabowski MKJournal: J Infect DisPMID: 37079374 November 2023

Herpes simplex virus type 2 (HSV-2) is an incurable sexually transmitted infection associated with increased risk of acquiring and transmitting…

Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea.

Author(s): Vegvari C, Grad YH, White PJ, Didelot X, Whittles LK, Scangarella-Oman NE, Mitrani-Gold FS, Dumont E, Perry CR, Gilchrist K, Hossain M, Mortimer TD, Anderson RM, Gardiner DJournal: Euro SurveillPMID: 33124551 October 2020

BackgroundThe first cases of extensively drug resistant gonorrhoea were recorded in the United Kingdom in 2018. There is a public…